Akero Therapeutics
AKRO
AKRO
57 hedge funds and large institutions have $422M invested in Akero Therapeutics in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
21.91% more ownership
Funds ownership: 44.62% → 66.53% (+22%)
6% more funds holding
Funds holding: 54 → 57 (+3)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.42M | |
| 2 | +$5.15M | |
| 3 | +$3.15M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.65M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.22M |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$1.67M | |
| 3 | -$1.4M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.22M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$615K |